CH605960A5 - - Google Patents

Info

Publication number
CH605960A5
CH605960A5 CH679875A CH679875A CH605960A5 CH 605960 A5 CH605960 A5 CH 605960A5 CH 679875 A CH679875 A CH 679875A CH 679875 A CH679875 A CH 679875A CH 605960 A5 CH605960 A5 CH 605960A5
Authority
CH
Switzerland
Application number
CH679875A
Inventor
Takanori Oe
Nakatsu Oita
Mineo Tsuruda
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Publication of CH605960A5 publication Critical patent/CH605960A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CH679875A 1974-05-28 1975-05-23 CH605960A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6063274A JPS5516432B2 (xx) 1974-05-28 1974-05-28

Publications (1)

Publication Number Publication Date
CH605960A5 true CH605960A5 (xx) 1978-10-13

Family

ID=13147870

Family Applications (1)

Application Number Title Priority Date Filing Date
CH679875A CH605960A5 (xx) 1974-05-28 1975-05-23

Country Status (12)

Country Link
US (1) US4085111A (xx)
JP (1) JPS5516432B2 (xx)
AT (1) AT347946B (xx)
BE (2) BE829474A (xx)
CA (1) CA1046064A (xx)
CH (1) CH605960A5 (xx)
DE (1) DE2521980C2 (xx)
FR (1) FR2279398A1 (xx)
GB (1) GB1466493A (xx)
NL (1) NL181408C (xx)
SE (1) SE425739B (xx)
ZA (1) ZA753091B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52105197A (en) * 1976-03-01 1977-09-03 Yoshitomi Pharmaceut Ind Ltd 1h-terazole derivatives
JPS5825677B2 (ja) * 1977-09-26 1983-05-28 武田薬品工業株式会社 ３−テトラゾ−ル−１−アザキサントン誘導体およびその製造法
JPS56100719A (en) * 1980-01-17 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Antirheumatic agent
US4555510A (en) * 1982-10-30 1985-11-26 Yoshitomi Pharmaceutical Industries, Ltd. Therapeutic agent for hypertension
FR2549831A1 (fr) * 1983-07-27 1985-02-01 Rhone Poulenc Agrochimie Nouveaux derives d'acides aryloxybenzoiques, et leur utilisation comme herbicides
US7320967B2 (en) * 2002-04-23 2008-01-22 L'oreal Cosmetic composition, method of cosmetic treatment and preparation of a composition for promoting the growth and/or preventing or delaying the loss of hair
JP4340545B2 (ja) * 2002-04-23 2009-10-07 ロレアル 毛髪の成長を促進し及び／又は抜毛を防止又は遅延化するための化粧品組成物
FR2838641B1 (fr) * 2002-04-23 2005-12-23 Oreal Composition cosmetique, procede de traitement cosmetique et preparation d'une composition pour favoriser la pousse et/ou empecher ou retarder la chute des cheveux
RS59018B1 (sr) 2013-06-27 2019-08-30 Pfizer Heteroaromatična jedinjenja i njihova upotreba kao dopamin d1 liganada

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2977372A (en) * 1958-04-09 1961-03-28 William G Finnegan Process for preparing substituted tetrazoles
US3536715A (en) * 1967-03-24 1970-10-27 Miles Lab 2-lower alkyl-5-(omega-(4-phenyl-1-piperazinyl) lower alkyl)-2h-tetrazoles
GB1362782A (en) * 1970-08-26 1974-08-07 Fisons Ltd Tetrazole derivatives
BE759292A (fr) * 1969-11-27 1971-05-24 Allen & Hanburys Ltd Derives de xanthone, leur preparation et leur emploi
GB1403487A (en) * 1972-07-21 1975-08-28 Yoshitomi Pharmaceutical Heterocyclic substituted alkanoic acids and derivatives
US3939173A (en) * 1972-09-06 1976-02-17 Burroughs Wellcome Co. Substituted carbonyl compounds
NL7403583A (xx) * 1973-03-19 1974-09-23

Also Published As

Publication number Publication date
BE888694Q (fr) 1981-08-28
FR2279398A1 (fr) 1976-02-20
ATA402475A (de) 1978-06-15
CA1046064A (en) 1979-01-09
SE425739B (sv) 1982-11-01
ZA753091B (en) 1976-04-28
BE829474A (fr) 1975-09-15
GB1466493A (en) 1977-03-09
NL181408B (nl) 1987-03-16
JPS5516432B2 (xx) 1980-05-01
JPS50151897A (xx) 1975-12-06
AT347946B (de) 1979-01-25
NL7506210A (nl) 1975-12-02
DE2521980C2 (de) 1985-08-22
SE7506058L (sv) 1975-12-01
FR2279398B1 (xx) 1980-02-15
AU8149875A (en) 1976-11-25
US4085111A (en) 1978-04-18
NL181408C (nl) 1987-08-17
DE2521980A1 (de) 1975-12-18

Similar Documents

Publication Publication Date Title
FR2257319B3 (xx)
FR2361398B1 (xx)
FR2267298B3 (xx)
FR2279398B1 (xx)
FR2265889A1 (xx)
JPS50143054A (xx)
IN143231B (xx)
JPS50117399U (xx)
FR2276536B3 (xx)
JPS50107311U (xx)
AU7459574A (xx)
JPS50133513A (xx)
JPS50120293U (xx)
AR198841Q (xx)
AU7237274A (xx)
JPS50100539A (xx)
JPS50128448U (xx)
JPS50116184A (xx)
JPS50121612A (xx)
BG21248A1 (xx)
BG21431A1 (xx)
BG21335A1 (xx)
BG20884A1 (xx)
BG20660A1 (xx)
AU480759A (xx)

Legal Events

Date Code Title Description
PL Patent ceased